PHYTOPHARM PLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for PHYTOPHARM PLC.The latest application filed is for "therapeutic methods and uses of sapogenins and their derivatives".
- PHYTOPHARM PLC - Godmanchester GB
- PHYTOPHARM PLC - Cambridgeshire GB
- Phytopharm PLC - Cambridge GB
- PHYTOPHARM PLC. -
- Phytopharm PLC - GB GB
- Phytopharm PLC. - Godmanchester GB
Trademarks
| Patent | Date |
|---|---|
| Therapeutic Methods And Uses Of Sapogenins And Their Derivatives App 20110190249 - REES; Daryl ; et al. | 2011-08-04 |
| Amorphous And Crystalline Forms Of Smilagenin And Its Hydrates App 20110144323 - TIFFIN; Peter David | 2011-06-16 |
| Hoodia plant extract with improved flavor Grant 7,923,435 - Batenburg , et al. April 12, 2 | 2011-04-12 |
| Processes for production of Hoodia plant extracts containing steroidal glycosides Grant 7,807,204 - Alaoui Ismaili , et al. October 5, 2 | 2010-10-05 |
| Stereospecific reduction of sapogen-3-ones Grant 7,718,792 - Gunning , et al. May 18, 2 | 2010-05-18 |
| Substituted Sapogenins And Their Use App 20100087411 - Barraclough; Paul ; et al. | 2010-04-08 |
| Chemical compounds Grant 7,589,123 - Rees , et al. September 15, 2 | 2009-09-15 |
| 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia Grant 7,507,720 - Barraclough , et al. March 24, 2 | 2009-03-24 |
| Substituted sapogenins and their use App 20080207576 - Barraclough; Paul ; et al. | 2008-08-28 |
| Chemical Compounds App 20080194530 - Tiffin; Peter David | 2008-08-14 |
| Smilagenin and its use Grant 7,368,137 - Xia , et al. May 6, 2 | 2008-05-06 |
| 5-Hydroxysapogenin derivatives with anti-dementia activity App 20080020021 - Barraclough; Paul ; et al. | 2008-01-24 |
| Sapogenin derivatives and their use in the treatment of cognitive dysfunction App 20080021004 - Barraclough; Paul ; et al. | 2008-01-24 |
| 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia App 20060276415 - Barraclough; Paul ; et al. | 2006-12-07 |
| 5-.beta.-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia Grant 7,138,427 - Barraclough , et al. November 21, 2 | 2006-11-21 |
| 5-hydroxysapogenin derivatives with anti-dementia activity App 20060165757 - Barraclough; Paul ; et al. | 2006-07-27 |
| Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use App 20060159779 - Rubin; Ian Duncan ; et al. | 2006-07-20 |
| Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use Grant 7,033,616 - Rubin , et al. April 25, 2 | 2006-04-25 |
| Stereospecific reduction of Sapogen-3-ones App 20060041119 - Gunning; Philip James ; et al. | 2006-02-23 |
| Steroidal sapogenins and their derivatives for treating alzheimer's disease Grant 6,812,213 - Xia , et al. November 2, 2 | 2004-11-02 |
| Gastric acid secretion Grant 6,808,723 - Hakkinen , et al. October 26, 2 | 2004-10-26 |
| Substituted sapogenins and their use App 20030158161 - Barraclough, Paul ; et al. | 2003-08-21 |
| Gastric acid secretion Grant 6,488,967 - Hakkinen , et al. December 3, 2 | 2002-12-03 |
| SEC | 0001296407 | PHYTOPHARM PLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 